Mead Johnson

Showing 1 posts of 1 posts found.

BMS profits buoyant after Mead Johnson jettisoned

February 1, 2010
Sales and Marketing 2009 financials, BMS, Mead Johnson

Bristol-Myers Squibb’s have revealed continued strong sales of the anti-blood clotting treatment Plavix and the antipsychotic Abilify and a huge …

The Gateway to Local Adoption Series

Latest content